• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MOBSTER R 包,用于从 bulk DNA 全基因组测序数据中推断肿瘤亚克隆。

The MOBSTER R package for tumour subclonal deconvolution from bulk DNA whole-genome sequencing data.

机构信息

University of Trieste, Trieste, Italy.

The Institute of Cancer Research, London, UK.

出版信息

BMC Bioinformatics. 2020 Nov 17;21(1):531. doi: 10.1186/s12859-020-03863-1.

DOI:10.1186/s12859-020-03863-1
PMID:33203356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7672894/
Abstract

BACKGROUND

The large-scale availability of whole-genome sequencing profiles from bulk DNA sequencing of cancer tissues is fueling the application of evolutionary theory to cancer. From a bulk biopsy, subclonal deconvolution methods are used to determine the composition of cancer subpopulations in the biopsy sample, a fundamental step to determine clonal expansions and their evolutionary trajectories.

RESULTS

In a recent work we have developed a new model-based approach to carry out subclonal deconvolution from the site frequency spectrum of somatic mutations. This new method integrates, for the first time, an explicit model for neutral evolutionary forces that participate in clonal expansions; in that work we have also shown that our method improves largely over competing data-driven methods. In this Software paper we present mobster, an open source R package built around our new deconvolution approach, which provides several functions to plot data and fit models, assess their confidence and compute further evolutionary analyses that relate to subclonal deconvolution.

CONCLUSIONS

We present the mobster package for tumour subclonal deconvolution from bulk sequencing, the first approach to integrate Machine Learning and Population Genetics which can explicitly model co-existing neutral and positive selection in cancer. We showcase the analysis of two datasets, one simulated and one from a breast cancer patient, and overview all package functionalities.

摘要

背景

从癌症组织的全基因组测序中获取大规模的全基因组测序谱,正在推动进化理论在癌症中的应用。从一个大块活检中,使用亚克隆反卷积方法来确定活检样本中癌症亚群的组成,这是确定克隆扩张及其进化轨迹的基本步骤。

结果

在最近的一项工作中,我们开发了一种新的基于模型的方法,从体细胞突变的位点频率谱中进行亚克隆反卷积。这种新方法首次整合了参与克隆扩张的中性进化力量的显式模型;在这项工作中,我们还表明,我们的方法大大优于竞争的数据驱动方法。在本软件论文中,我们介绍了 mobster,这是一个围绕我们新的反卷积方法构建的开源 R 包,它提供了几个函数来绘制数据和拟合模型,评估它们的置信度,并计算与亚克隆反卷积相关的进一步进化分析。

结论

我们提出了用于从批量测序中进行肿瘤亚克隆反卷积的 mobster 包,这是第一个将机器学习和群体遗传学集成在一起的方法,可以明确地对癌症中同时存在的中性和阳性选择进行建模。我们展示了对两个数据集的分析,一个是模拟的,一个是来自乳腺癌患者的,概述了所有的包功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df2/7672894/0f97c3881066/12859_2020_3863_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df2/7672894/b83f7ccd8bba/12859_2020_3863_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df2/7672894/7888919939fc/12859_2020_3863_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df2/7672894/0f97c3881066/12859_2020_3863_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df2/7672894/b83f7ccd8bba/12859_2020_3863_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df2/7672894/7888919939fc/12859_2020_3863_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df2/7672894/0f97c3881066/12859_2020_3863_Fig3_HTML.jpg

相似文献

1
The MOBSTER R package for tumour subclonal deconvolution from bulk DNA whole-genome sequencing data.MOBSTER R 包,用于从 bulk DNA 全基因组测序数据中推断肿瘤亚克隆。
BMC Bioinformatics. 2020 Nov 17;21(1):531. doi: 10.1186/s12859-020-03863-1.
2
Subclonal reconstruction of tumors by using machine learning and population genetics.利用机器学习和群体遗传学进行肿瘤亚克隆重建。
Nat Genet. 2020 Sep;52(9):898-907. doi: 10.1038/s41588-020-0675-5. Epub 2020 Sep 2.
3
Benchmarking pipelines for subclonal deconvolution of bulk tumour sequencing data.对批量肿瘤测序数据进行亚克隆分解的基准测试管道。
Nat Commun. 2021 Nov 4;12(1):6396. doi: 10.1038/s41467-021-26698-7.
4
MixClone: a mixture model for inferring tumor subclonal populations.MixClone:一种用于推断肿瘤亚克隆群体的混合模型。
BMC Genomics. 2015;16 Suppl 2(Suppl 2):S1. doi: 10.1186/1471-2164-16-S2-S1. Epub 2015 Jan 21.
5
Quantifying the influence of mutation detection on tumour subclonal reconstruction.量化突变检测对肿瘤亚克隆重建的影响。
Nat Commun. 2020 Dec 7;11(1):6247. doi: 10.1038/s41467-020-20055-w.
6
Integrative inference of subclonal tumour evolution from single-cell and bulk sequencing data.从单细胞和批量测序数据推断亚克隆肿瘤进化。
Nat Commun. 2019 Jun 21;10(1):2750. doi: 10.1038/s41467-019-10737-5.
7
Quantification of subclonal selection in cancer from bulk sequencing data.从 bulk 测序数据中定量癌症中的亚克隆选择。
Nat Genet. 2018 Jun;50(6):895-903. doi: 10.1038/s41588-018-0128-6. Epub 2018 May 28.
8
Cell subpopulation deconvolution reveals breast cancer heterogeneity based on DNA methylation signature.细胞亚群反卷积基于DNA甲基化特征揭示乳腺癌异质性。
Brief Bioinform. 2017 May 1;18(3):426-440. doi: 10.1093/bib/bbw028.
9
Subclonal diversification of primary breast cancer revealed by multiregion sequencing.多区域测序揭示原发性乳腺癌的亚克隆多样性
Nat Med. 2015 Jul;21(7):751-9. doi: 10.1038/nm.3886. Epub 2015 Jun 22.
10
Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns.通过全基因组测序监测慢性淋巴细胞白血病的进展揭示了异质性的克隆进化模式。
Blood. 2012 Nov 15;120(20):4191-6. doi: 10.1182/blood-2012-05-433540. Epub 2012 Aug 22.

引用本文的文献

1
Antimutator and Mutational Spectrum Effects Can Combine to Reduce Evolutionary Potential in Escherichia coli ΔnudJ.抗突变剂和突变谱效应可共同降低大肠杆菌ΔnudJ的进化潜力。
Mol Biol Evol. 2025 Jul 30;42(8). doi: 10.1093/molbev/msaf182.
2
Competing Subclones and Fitness Diversity Shape Tumor Evolution Across Cancer Types.相互竞争的亚克隆和适应性多样性塑造了不同癌症类型的肿瘤进化。
bioRxiv. 2025 Jun 3:2025.05.31.657191. doi: 10.1101/2025.05.31.657191.
3
Advancing precision oncology with AI-powered genomic analysis.通过人工智能驱动的基因组分析推动精准肿瘤学发展。

本文引用的文献

1
Subclonal reconstruction of tumors by using machine learning and population genetics.利用机器学习和群体遗传学进行肿瘤亚克隆重建。
Nat Genet. 2020 Sep;52(9):898-907. doi: 10.1038/s41588-020-0675-5. Epub 2020 Sep 2.
2
Resolving genetic heterogeneity in cancer.解析癌症中的遗传异质性。
Nat Rev Genet. 2019 Jul;20(7):404-416. doi: 10.1038/s41576-019-0114-6.
3
Evolutionary dynamics of residual disease in human glioblastoma.人类胶质母细胞瘤残留病灶的进化动态。
Front Pharmacol. 2025 Apr 30;16:1591696. doi: 10.3389/fphar.2025.1591696. eCollection 2025.
4
Oncogene aberrations drive medulloblastoma progression, not initiation.癌基因畸变驱动髓母细胞瘤进展,而非起始。
Nature. 2025 May 7. doi: 10.1038/s41586-025-08973-5.
5
The Evolutionary Interplay of Somatic and Germline Mutation Rates.体细胞突变率与种系突变率的进化相互作用
Annu Rev Biomed Data Sci. 2024 Aug;7(1):83-105. doi: 10.1146/annurev-biodatasci-102523-104225. Epub 2024 Jul 24.
6
Computational validation of clonal and subclonal copy number alterations from bulk tumor sequencing using CNAqc.使用 CNAqc 对肿瘤测序的克隆和亚克隆拷贝数改变进行计算验证。
Genome Biol. 2024 Jan 31;25(1):38. doi: 10.1186/s13059-024-03170-5.
7
Clinical application of tumour-in-normal contamination assessment from whole genome sequencing.基于全基因组测序的肿瘤-正常污染评估的临床应用。
Nat Commun. 2024 Jan 18;15(1):323. doi: 10.1038/s41467-023-44158-2.
8
Bioinformatics roadmap for therapy selection in cancer genomics.癌症基因组学治疗选择的生物信息学路线图。
Mol Oncol. 2022 Nov;16(21):3881-3908. doi: 10.1002/1878-0261.13286. Epub 2022 Aug 20.
9
J-SPACE: a Julia package for the simulation of spatial models of cancer evolution and of sequencing experiments.J-SPACE:一个用于模拟癌症进化和测序实验的空间模型的 Julia 包。
BMC Bioinformatics. 2022 Jul 8;23(1):269. doi: 10.1186/s12859-022-04779-8.
10
Measuring competitive exclusion in non-small cell lung cancer.测量非小细胞肺癌中的竞争排斥。
Sci Adv. 2022 Jul;8(26):eabm7212. doi: 10.1126/sciadv.abm7212. Epub 2022 Jul 1.
Ann Oncol. 2019 Mar 1;30(3):456-463. doi: 10.1093/annonc/mdy506.
4
Detecting repeated cancer evolution from multi-region tumor sequencing data.从多区域肿瘤测序数据中检测癌症的重复进化。
Nat Methods. 2018 Sep;15(9):707-714. doi: 10.1038/s41592-018-0108-x. Epub 2018 Aug 31.
5
Quantification of subclonal selection in cancer from bulk sequencing data.从 bulk 测序数据中定量癌症中的亚克隆选择。
Nat Genet. 2018 Jun;50(6):895-903. doi: 10.1038/s41588-018-0128-6. Epub 2018 May 28.
6
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.追踪癌症演进揭示转移受限途径:TRACERx 肾脏。
Cell. 2018 Apr 19;173(3):581-594.e12. doi: 10.1016/j.cell.2018.03.057. Epub 2018 Apr 12.
7
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.确定性进化轨迹影响原发性肿瘤生长:TRACERx 肾脏。
Cell. 2018 Apr 19;173(3):595-610.e11. doi: 10.1016/j.cell.2018.03.043. Epub 2018 Apr 12.
8
Universal Patterns of Selection in Cancer and Somatic Tissues.癌症和体细胞组织中的普遍选择模式。
Cell. 2017 Nov 16;171(5):1029-1041.e21. doi: 10.1016/j.cell.2017.09.042. Epub 2017 Oct 19.
9
Tracking the Evolution of Non-Small-Cell Lung Cancer.跟踪非小细胞肺癌的演变。
N Engl J Med. 2017 Jun 1;376(22):2109-2121. doi: 10.1056/NEJMoa1616288. Epub 2017 Apr 26.
10
Algorithmic methods to infer the evolutionary trajectories in cancer progression.推断癌症进展中进化轨迹的算法方法。
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):E4025-34. doi: 10.1073/pnas.1520213113. Epub 2016 Jun 28.